MedTrace Logo

MGC Health COVID-19 & Flu A+B Home Multi Test Usability Study

NCT05732610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-05-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the usability of the MGC Health COVID-19 \& Flu A+B Home Multi Test in home use.

Conditions

Interventions

DIAGNOSTIC_TEST

MGC Health COVID-19 & Flu A+B Home Multi Test

self-collected direct anterior nares swab samples

DIAGNOSTIC_TEST

MGC Health COVID-19 & Flu A+B Home Multi Test (2 to 13 y/o)

adult lay user collected anterior nares swab sample

Sponsors & Collaborators

  • CSSi Life Sciences

    collaborator INDUSTRY

  • Medical Group Care, LLC

    lead INDUSTRY

Principal Investigators

  • Janice Cattano, RN, MSN · CSSi LifeSciences

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-14
Primary Completion
2023-02-28
Completion
2023-03-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05732610 on ClinicalTrials.gov